Skip to main content
Top
Literature
1.
go back to reference Ghosal SP, Mukherjee AK, Mukherjee D et al (1988) Diaphyseal dysplasia associated with anemia. J Pediatr 113:49–57. Erratum in: J Pediatr 1988; 113(2):410 Ghosal SP, Mukherjee AK, Mukherjee D et al (1988) Diaphyseal dysplasia associated with anemia. J Pediatr 113:49–57. Erratum in: J Pediatr 1988; 113(2):410
3.
go back to reference Arora R, Aggarwal S, Deme S (2015) Ghosal hematodiaphyseal dysplasia—a concise review including an illustrative patient. Skeletal Radiol 44:447–450CrossRefPubMed Arora R, Aggarwal S, Deme S (2015) Ghosal hematodiaphyseal dysplasia—a concise review including an illustrative patient. Skeletal Radiol 44:447–450CrossRefPubMed
5.
go back to reference John RR, Boddu D, Chaudhary N et al (2015) Steroid-responsive anemia in patients of Ghosal hematodiaphyseal dysplasia: simple to diagnose and easy to treat. J Pediatr Hematol Oncol 37(4):285–289CrossRefPubMed John RR, Boddu D, Chaudhary N et al (2015) Steroid-responsive anemia in patients of Ghosal hematodiaphyseal dysplasia: simple to diagnose and easy to treat. J Pediatr Hematol Oncol 37(4):285–289CrossRefPubMed
Metadata
Title
Ghosal Hemato-diaphyseal Dysplasia: A Rare Variety of Hypoplastic Anemia with Good Response to Steroid Therapy
Authors
Pushpa Gurudas Kini
Sandeep Kumar
Adel Moideen
Adarsh Tulasidhar Narain
Publication date
01-01-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0818-8

Other articles of this Issue 1/2018

Indian Journal of Hematology and Blood Transfusion 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine